Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Dr Barry Katzen
AMP 2024
The CLI Global Society: Why Is Membership Important?
09/10/2024
Watch as Dr. Barry Katzen, president and founding board member of the CLI Global Society, discusses the importance of membership in the Society.
Watch as Dr. Barry Katzen, president and founding board member of the CLI Global Society, discusses the importance of membership in the Society.
Watch as Dr. Barry Katzen,...
09/10/2024
Vascular Disease Management
John Rundback MD
AMP 2024
Auryon Laser for the Treatment of Diabetic Patients: A Subgroup Analysis of the PATHFINDER Registry
09/10/2024
Watch as John Rundback, MD, from Advanced Interventional & Vascular Services in New Jersey, discusses his presentation on the PATHFINDER Registry at AMP 2024.
Watch as John Rundback, MD, from Advanced Interventional & Vascular Services in New Jersey, discusses his presentation on the PATHFINDER Registry at AMP 2024.
Watch as John Rundback, MD, from...
09/10/2024
Vascular Disease Management
S Jay Mathews
AMP 2024
Retrievable Stent Therapy for CLTI: Update on the DEEPER REVEAL Trial
09/09/2024
In this video recorded at AMP 2024, S. Jay Mathews, MD, provides an update on the latest results from the DEEPER REVEAL trial.
In this video recorded at AMP 2024, S. Jay Mathews, MD, provides an update on the latest results from the DEEPER REVEAL trial.
In this video recorded at AMP...
09/09/2024
Vascular Disease Management
Using Data to Determine Your Treatment Algorithm for Complex SFA Lesions
Sponsored Video
Using Data to Determine Your Treatment Algorithm for Complex SFA Lesions
08/23/2024
Watch this live case symposium and expert panel discussion on drug elution and vessel prep treatment algorithms featuring Drs. Eric Secemsky, Zola N'Dandu, Sonya Noor, and Robert Lookstein that was recorded at AMP 2024.
Watch this live case symposium and expert panel discussion on drug elution and vessel prep treatment algorithms featuring Drs. Eric Secemsky, Zola N'Dandu, Sonya Noor, and Robert Lookstein that was recorded at AMP 2024.
Watch this live case symposium...
08/23/2024
Vascular Disease Management
Abigail Mize
AMP 2024
Fluoroscopic and Ultrasound Criteria for Patient Selection in DVA
08/17/2024
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria. 
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria. 
During her Saturday presentation...
08/17/2024
Vascular Disease Management
Dr Pliagas
AMP 2024
Retrospective Analysis of Peripheral Vascular Intervention Procedural and Safety Outcomes With Utilization of the Glidesheath Slender for Tibiopedal Access
08/16/2024
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
On Friday, George Pliagas, MD,...
08/16/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
Endovascular Treatment of Femoropopliteal Arterial Occlusive Disease With Multiple Sirolimus-Eluting, Balloon-Expandable, Bioresorbable Vascular Scaffolds: The Efemoral Vascular Scaffold System
08/16/2024
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
In a presentation on Friday...
08/16/2024
Vascular Disease Management
Dr Mazin Foteh
AMP 2024
Reperfusion Injury vs Compartment Syndrome: Differential Diagnosis and Management
08/15/2024
On Thursday afternoon, Mazin Foteh, MD, provided an in-depth examination of reperfusion injury and compartment syndrome, focusing on their differential diagnosis and management strategies.
On Thursday afternoon, Mazin Foteh, MD, provided an in-depth examination of reperfusion injury and compartment syndrome, focusing on their differential diagnosis and management strategies.
On Thursday afternoon, Mazin...
08/15/2024
Vascular Disease Management
Dr Kevin Rogers
AMP 2024
The Potential Value of Anticoagulation/Anti-Platelet Therapy in CLTI Patients
08/15/2024
On Thursday afternoon, R. Kevin Rogers, MD, spoke about the role of antithrombotic therapy in managing patients with CLTI, particularly those undergoing lower extremity revascularization.
On Thursday afternoon, R. Kevin Rogers, MD, spoke about the role of antithrombotic therapy in managing patients with CLTI, particularly those undergoing lower extremity revascularization.
On Thursday afternoon, R. Kevin...
08/15/2024
Vascular Disease Management
Dr Sonya Noor
AMP 2024
The Logic Behind Leaving Nothing Behind
08/15/2024
During the “Vessel Preparation for CLI” session on Thursday morning. Sonya Noor, MD, from the Gates Vascular Institute in Buffalo, New York, gave a presentation that focused on the strategic use of atherectomy in vascular interventions,...
During the “Vessel Preparation for CLI” session on Thursday morning. Sonya Noor, MD, from the Gates Vascular Institute in Buffalo, New York, gave a presentation that focused on the strategic use of atherectomy in vascular interventions,...
During the “Vessel Preparation...
08/15/2024
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement